FDA label
What is Azopt used for?
Azopt contains brinzolamide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Azopt?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Azopt, suspension/ drops
Indications and Usage, quoted from the label by Sandoz Inc (NDA020816). Cross-references to other label sections are left out.
AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
Source: DailyMed label, set id 0afb6589-51ba-432c-aed1-20a12d5d3455, version 1, effective November 24, 2023. NDC 66758-085, one of 1 listing for this product.
Questions
What is Azopt used for?
The FDA label says: “AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.”
What drug class is Azopt?
FDA lists brinzolamide in the Carbonic Anhydrase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.